Mint's Axonex Signs €3M OEM Deal with Ireland's Centridex to Enter Europe
MIMI sits 39% above its 52-week low of $0.61.
Summary
Mint's majority-owned Axonex Robotics signed a two-year OEM supply and license agreement with Ireland-based Centridex, with a total potential value of about €3 million. The deal includes an initial order package worth roughly €450,000 covering robot kits, platform licensing, and related services. Centridex will assemble, test, and distribute the robots in Ireland and other selected markets, giving Axonex a European distribution channel. This follows a series of dilutive financings and a blocked share authorization, so the agreement offers a non-dilutive revenue opportunity. The programme runs from October 1, 2026 to September 30, 2028, with future purchase orders to be implemented under the framework.
At the time of this announcement, MIMI was trading at $0.85 on NASDAQ in the Technology sector, with a market capitalization of approximately $12.6M. The 52-week trading range was $0.61 to $92.80. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.